(Q36421163)

14 August 2017

1 reference

title

Diagnosis and management of clinical and subclinical cobalamin deficiency: advances and controversies (English)

1 reference

14 August 2017

Ralph Carmel

1

1 reference

14 August 2017

Mona Sarrai

series ordinal

2

1 reference

14 August 2017

publication date

1 March 2006

1 reference

Current hematology reports

14 August 2017

published in

1 reference

14 August 2017

volume

5

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

23-33

1 reference

The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma

14 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11901-006-0019-7

Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11901-006-0019-7

Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma

21 January 2018

2 references

Crossref

https://api.crossref.org/works/10.1007%2FS11901-006-0019-7

21 January 2018

12 December 2020

Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen

1 reference

12 December 2020

Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence

1 reference

12 December 2020

Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients

1 reference

12 December 2020

Hepatitis B virus. The major etiology of hepatocellular carcinoma

1 reference

12 December 2020

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

12 December 2020

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen

1 reference

12 December 2020

Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection.

1 reference

12 December 2020

Spontaneous loss of HBsAg in children with chronic hepatitis B virus infection

1 reference

12 December 2020

Hepatitis B virus DNA in peripheral-blood mononuclear cells in chronic hepatitis B after HBsAg clearance

1 reference

12 December 2020

Immunoassay detection of hepatitis B surface antigen mutants

1 reference

12 December 2020

1 reference

12 December 2020

Clearance of HBsAg in seven patients with chronic hepatitis B

1 reference

12 December 2020

Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays

1 reference

12 December 2020

Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance

1 reference

12 December 2020

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

1 reference

12 December 2020

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection

1 reference

12 December 2020

The Liver Histology and Frequency of Clearance of the Hepatitis B Surface Antigen (HBsAg) in Chronic Carriers

1 reference

12 December 2020

Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg

1 reference

12 December 2020

Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

12 December 2020

HBsAg seroclearance in Chinese patients receiving lamivudine therapy for chronic hepatitis B virus infection.

1 reference

12 December 2020

Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B.

1 reference

12 December 2020

Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma

1 reference

12 December 2020

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

12 December 2020

Occult hepatitis B virus infection: a hidden menace?

1 reference

12 December 2020

Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?

1 reference

12 December 2020

1 reference

12 December 2020

Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis

1 reference

12 December 2020

Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen

1 reference

12 December 2020

Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California

1 reference

12 December 2020

Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study

1 reference

12 December 2020

Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands, Japan.

1 reference

12 December 2020

Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B.

1 reference

12 December 2020

10.1007/S11901-006-0019-7

Identifiers

DOI

1 reference

release_z6br4xafi5hljpthya322d5cim

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z6br4xafi5hljpthya322d5cim

24 November 2022

mapped directly with Wikidata item

1 reference